Tilray stock soared after an agreement with Grow Pharma to import and distribute its medical cannabis products in the United Kingdom.
Tilray shares surge nearly 40% on deal to import and distribute medical cannabis in the UK

Tilray stock soared after an agreement with Grow Pharma to import and distribute its medical cannabis products in the United Kingdom.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies.